Wonbiogen, a specialized bio-medical device company led by CEO Kim Won-il, announced that it successfully concluded its participation in 'MEDICA 2025,' the world's largest medical device exhibition held in Düsseldorf, Germany, by conducting over 180 export consultations with global buyers.

At this exhibition, Wonbiogen focused on promoting the technological prowess of its core business, wound dressing. The company stated that once the acquisition of the 'CE MDR (Medical Device Regulation)' certification, considered a crucial gateway and one of the most stringent regulations for entering the European market, is completed next year, export opportunities will significantly expand across Europe and other global countries adopting this standard.

On-site, Wonbiogen's main product lines, including hydrocolloid and foam dressings, were evaluated as having quality and price competitiveness comparable to those of leading global companies, leading to detailed supply discussions.

Additionally, there was significant interest in Wonbiogen's 'medical cosmetic' lineup, which incorporates its proprietary medical device technology. Products such as the Body Shield Cream, EGF Repair Cream, and Beauty Spot Patch attracted buyers' attention, based on the trustworthiness of being cosmetics made by a medical device company. This reflects the global trend of increasing demand for high-functionality products that aid in skin protection and regeneration, according to the company.

Wonbiogen reported that during the four-day exhibition, it conducted 1:1 business consultations with over 180 overseas distributors and medical institutions. This represents both quantitative and qualitative growth compared to last year, aligning with the heightened local interest in K-medical devices and increasing the likelihood of contract success.

A Wonbiogen representative stated, "The acquisition of CE MDR certification next year will be a crucial momentum for Wonbiogen to advance as a global top-tier company," adding, "With the expansion of the wound dressing market in Europe and the confirmed demand for cosmetic products on-site, next year's sales growth is anticipated."

The representative continued, "Based on these achievements and confidence, we plan to significantly expand our exhibition booth size at MEDICA 2026 compared to this year," expressing the ambition to "showcase a diverse product lineup in a larger space and aggressively increase our global market share."

Popular News